| Literature DB >> 33672218 |
Marceau Quatredeniers1,2, Pedro Mendes-Ferreira3,4, Diana Santos-Ribeiro5, Morad K Nakhleh1,2, Maria-Rosa Ghigna1,2, Sylvia Cohen-Kaminsky1,2, Frédéric Perros1,2,4.
Abstract
Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease that is caused by the progressive occlusion of the distal pulmonary arteries, eventually leading to right heart failure and death. Almost 40% of patients with PAH are iron deficient. Although widely studied, the mechanisms linking between PAH and iron deficiency remain unclear. Here we review the mechanisms regulating iron homeostasis and the preclinical and clinical data available on iron deficiency in PAH. Then we discuss the potential implications of iron deficiency on the development and management of PAH.Entities:
Keywords: cardiovascular disease; iron deficiency; iron homeostasis; pulmonary arterial hypertension
Year: 2021 PMID: 33672218 DOI: 10.3390/cells10020477
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600